Köster A, Saftig P, Matzner U, von Figura K, Peters C, Pohlmann R
Universität Göttingen, Germany.
EMBO J. 1993 Dec 15;12(13):5219-23. doi: 10.1002/j.1460-2075.1993.tb06217.x.
Lysosomal enzymes containing mannose 6-phosphate recognition markers are sorted to lysosomes by mannose 6-phosphate receptors (MPRs). The physiological importance of this targeting mechanism is illustrated by I-cell disease, a fatal lysosomal storage disorder caused by the absence of mannose 6-phosphate residues in lysosomal enzymes. Most mammalian cells express two MPRs. Although the binding specificities, subcellular distribution and expression pattern of the two receptors can be differentiated, their coexpression is not understood. The larger of the two receptors with an M(r) of approximately 300,000 (MPR300), which also binds IGFII, appears to have a dominant role in lysosomal enzyme targeting, while the function of the smaller receptor with an M(r) of 46,000 (MPR46) is less clear. To investigate the in vivo function of the MPR46, we generated MPR46-deficient mice using gene targeting in embryonic stem cells. Reduced intracellular retention of newly synthesized lysosomal proteins in cells from MPR46 -/- mice demonstrated an essential sorting function of MPR46. The phenotype of MPR46 -/- mice was normal, indicating mechanisms that compensate the MPR46 deficiency in vivo.
含有甘露糖-6-磷酸识别标记的溶酶体酶通过甘露糖-6-磷酸受体(MPRs)被分选到溶酶体中。I型细胞病说明了这种靶向机制的生理重要性,I型细胞病是一种致命的溶酶体贮积症,由溶酶体酶中缺乏甘露糖-6-磷酸残基引起。大多数哺乳动物细胞表达两种MPR。虽然这两种受体的结合特异性、亚细胞分布和表达模式可以区分,但它们的共表达情况尚不清楚。两种受体中较大的一种,分子量约为300,000(MPR300),也能结合胰岛素样生长因子II(IGFII),似乎在溶酶体酶靶向中起主导作用,而较小的受体,分子量为46,000(MPR46)的功能则不太清楚。为了研究MPR46在体内的功能,我们利用胚胎干细胞基因靶向技术培育出了MPR46缺陷小鼠。MPR46 -/-小鼠细胞中新合成的溶酶体蛋白细胞内滞留减少,证明了MPR46的基本分选功能。MPR46 -/-小鼠的表型正常,表明体内存在补偿MPR46缺陷的机制。